| View |
|
DRP-10024-02
|
Ascorbic Acid + Zinc
|
Lab-Cee
|
500 mg (equivalent to 562.5 mg Sodium Ascorbate)/40 mg (equivalent to 109.8 mg Zinc Sulfate Monohydrate)
|
Capsule
|
Vitamin / Mineral
|
Azarias Pharmaceutical Laboratories Inc,
|
Philippines
|
Initial
|
23 May 2022
|
13 July 2026
|
| View |
|
DRP-10025
|
Ascorbic Acid + Zinc
|
Enoznc
|
500 mg (equivalent to 562.5 mg Sodium Ascorbate) /
40 mg (equivalent to 109.8 mg Zinc Sulfate Monohydrate)
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
-
|
13 July 2021
|
13 July 2026
|
| View |
|
DRP-10026
|
Ascorbic Acid + Zinc
|
Pharcee Plus
|
500 mg (equivalent to 562.5 mg Sodium Ascorbate) /
40 mg (equivalent to 109.8 mg Zinc Sulfate Monohydrate)
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
-
|
13 July 2021
|
13 July 2026
|
| View |
|
DRP-10027
|
Ascorbic Acid + Zinc
|
Actcee Plus
|
500 mg (equivalent to 562.5 mg Sodium Ascorbate) /
40 mg (equivalent to 109.8 mg Zinc Sulfate Monohydrate)
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
-
|
13 July 2021
|
13 July 2026
|
| View |
|
DRP-10028
|
Ascorbic Acid + Zinc
|
Actcee Plus
|
500 mg (equivalent to 562.5 mg Sodium Ascorbate) /
40 mg (equivalent to 109.8 mg Zinc Sulfate Monohydrate)
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
-
|
13 July 2021
|
13 July 2026
|
| View |
|
DRP-10029
|
Ascorbic Acid + Zinc
|
Endurecee Plus
|
500 mg (equivalent to 562.5 mg Sodium Ascorbate) /
40 mg (equivalent to 109.8 mg Zinc Sulfate Monohydrate)
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories, Inc
|
Philippines
|
-
|
13 July 2021
|
13 July 2026
|
| View |
|
DRP-10030
|
Ascorbic Acid + Zinc
|
Strongcee Plus
|
500 mg (equivalent to 562.5 mg Sodium Ascorbate) /
40 mg (equivalent to 109.8 mg Zinc Sulfate Monohydrate)
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
-
|
13 July 2021
|
13 July 2026
|
| View |
|
DRP-10031
|
Ascorbic Acid + Zinc
|
Supraznc
|
500 mg (equivalent to 562.5 mg Sodium Ascorbate) / 40 mg (equivalent to 109.8 mg Zinc Sulfate Monohydrate)
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
-
|
13 July 2021
|
13 July 2026
|
| View |
|
DRP-10032
|
Ascorbic Acid + Zinc
|
Znc4te
|
500 mg (equivalent to 562.5 mg Sodium Ascorbate) /
40 mg (equivalent to 109.8 mg Zinc Sulfate
Monohydrate)
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories, Inc
|
Philippines
|
-
|
13 July 2021
|
13 July 2026
|
| View |
|
DRP-10033
|
Ascorbic Acid + Zinc
|
Ascozin Max
|
1000 mg (equivalent to 1125 mg Sodium Ascorbate) /
10 mg (equivalent to 96.16 mg Zinc Citrate
Trihydrate)
|
Effervescent Tablet
|
Vitamin / Mineral
|
Kusum Healthcare Private Limited
|
India
|
Initial (OTC)
|
13 July 2021
|
13 July 2026
|
| View |
|
DRP-10034
|
Mupirocin
|
Mupihab
|
20 mg / g
|
Ointment
|
-
|
Taiguk Pharm. Co., Ltd.
|
Korea
|
Initial [PCPR] [OTC]
|
12 July 2021
|
12 July 2026
|
| View |
|
DRP-10034-01
|
Mupirocin
|
Mupisenz
|
20 mg/g
|
Ointment
|
Antibacterial
|
Taiguk Pharm. Co., Ltd.
|
Korea
|
CLIDP
|
11 January 2022
|
12 July 2026
|
| View |
|
DRP-10035
|
Salbutamol
|
Adosal
|
2 mg / 5 mL
|
Oral Solution
|
-
|
Rhydburg Pharmaceuticals Limited
|
India
|
-
|
03 September 2021
|
03 September 2026
|
| View |
|
DRP-10035-01
|
Salbutamol (As Sulfate)
|
Retavent
|
2mg/5mL
|
Oral Solution
|
Selective Beta-2-Adrenoreceptor Agonist
|
Rhydburg Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
18 October 2023
|
03 September 2026
|
| View |
|
DRP-10037
|
Clopidogrel
|
Clotfre
|
75 mg
|
Film-Coated Tablet
|
-
|
Raptakos Brett & Co. Ltd.
|
India
|
-
|
13 July 2021
|
06 August 2025
|
| View |
|
DRP-10038
|
Salbutamol (as Sulfate)
|
Durasal-CR
|
4 mg
|
Controlled Release Capsule
|
Anti-asthma
|
Raptakos Brett & Co., Ltd.
|
India
|
Renewal
|
20 February 2024
|
10 July 2029
|
| View |
|
DRP-10039
|
Metformin (as Hydrochloride) + Glibenclamide
|
Diacom
|
500mg/5mg
|
Film-Coated Tablet
|
-
|
Hovid Berhad
|
Malaysia
|
-
|
13 July 2021
|
31 May 2026
|
| View |
|
DRP-10040
|
Gliclazide
|
Glubitor-Od
|
30 mg
|
Modified-Release Tablet
|
Oral Hypoglycemic (Sulfonylurea)
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
15 March 2022
|
06 June 2027
|
| View |
|
DRP-10041
|
Glimepiride
|
Norizec
|
3 mg
|
Tablet
|
Sulfonylurea
|
Amherst Laboratories, Inc.
|
Philippines
|
Renewal
|
21 June 2022
|
09 July 2027
|
| View |
|
DRP-10042
|
Metformin hydrochloride
|
Glumet-XR
|
500 mg
|
Extended-Release Tablet
|
Oral Hypoglycemic
|
Amherst Laboratories, Inc.
|
Philippines
|
Renewal
|
22 November 2023
|
16 February 2029
|